Hydrochloric Acid → HCID 178505550, compound

HRID 538414Notes

Reaction equation

HRID 538414 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:9](COCC[Si](C)(C)C)[C:10]([C:19]3[CH:20]=[C:21]4[CH:27]=[CH:26][NH:25][C:22]4=[N:23][CH:24]=3)=[C:11]([C:13]3[CH:18]=[CH:17][N:16]=[CH:15][CH:14]=3)[N:12]=2)=[CH:4][CH:3]=1.C1C(=O)N([Cl:43])C(=O)C1.Cl>C(#N)C>[Cl:43][C:27]1[C:21]2[C:22](=[N:23][CH:24]=[C:19]([C:10]3[NH:9][C:8]([C:5]4[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=4)=[N:12][C:11]=3[C:13]3[CH:18]=[CH:17][N:16]=[CH:15][CH:14]=3)[CH:20]=2)[NH:25][CH:26]=1

Participants

5

Conditions

Temperature
60 °C

Procedure

To a solution of 5-(2-(4-fluorophenyl)-4-(pyridin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine (18 mg, 0.04 mmol) in ACN (0.6 mL) was added NCS (5 mg, 0.04 mmol). After stirring for 18 h, the reaction mixture was partitioned between EtOAc (20 mL) and aqueous saturated NaHCO3 (10 mL). The layers were separated and the organic phase was washed with aqueous 0.1 M HCl solution (10 mL), brine (10 mL), and dried (Na2SO4). After concentrating in vacuo, the resulting crude product was dissolved in ethanol (1.5 mL) and conc. HCl (0.25 mL, 3 mmol) was added and the reaction was heated at 60° C. for 20 min and then concentrated in vacuo. The crude material was dissolved in DMSO (1.3 mL) and purified by reverse phase HPLC, which after lypholization, yielded 7 mg (38%) of the title compound as the TFA salt: —LC/MS (m/z): 390.1 (MH+), tR=0.67 min.

Workup

  1. customthe reaction mixture was partitioned between EtOAc (20 mL) and aqueous saturated NaHCO3 (10 mL)
  2. customThe layers were separated
  3. washthe organic phase was washed with aqueous 0.1 M HCl solution (10 mL), brine (10 mL)
  4. dry with materialdried (Na2SO4)
  5. concentrationAfter concentrating in vacuo
  6. dissolutionthe resulting crude product was dissolved in ethanol (1.5 mL)
  7. concentrationconcentrated in vacuo
  8. dissolutionThe crude material was dissolved in DMSO (1.3 mL)
  9. custompurified by reverse phase HPLC, which after lypholization

Sources & evidence

ORD record
ord-e0b6336222fa4861996fcb8e4423c66c
Source dataset
uspto-grants-2014_10
Patent number
US08865732B2

Reaction notes

Loading…